These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22112778)

  • 21. Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.
    Barnhart MK; Cartmill B; Ward EC; Brown E; Sim J; Saade G; Rayner S; Robinson RA; Simms VA; Smee RI
    Dysphagia; 2019 Dec; 34(6):869-878. PubMed ID: 30741335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy.
    Fiorino C; Dell'Oca I; Pierelli A; Broggi S; De Martin E; Di Muzio N; Longobardi B; Fazio F; Calandrino R
    Radiother Oncol; 2006 Mar; 78(3):276-82. PubMed ID: 16546279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technical challenges of sparing infrahyoid swallowing organs at risk in oropharynx squamous cell cancer treated with IMRT.
    Morley L; Tsang SW; Breen SL; Waldron JN; Maganti M; Pintilie M; Dawson LA; Ringash J; Huang SH; Kim J
    Med Dosim; 2014; 39(2):146-51. PubMed ID: 24440166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer.
    Krayenbuehl J; Davis JB; Ciernik IF
    Radiother Oncol; 2006 Nov; 81(2):151-7. PubMed ID: 17055095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site.
    Bhide S; Clark C; Harrington K; Nutting CM
    Med Dosim; 2007; 32(3):188-95. PubMed ID: 17707198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
    Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protons in head-and-neck cancer: bridging the gap of evidence.
    Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
    Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major reduction of monitor units with the avoidance of leaf-sequencing step by direct aperture based IMRT optimisation.
    Seppälä J; Lahtinen T; Kolmonen P
    Acta Oncol; 2009; 48(3):426-30. PubMed ID: 18766997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
    Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
    Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
    Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
    Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical considerations in reducing swallowing dysfunction following concurrent chemoradiotherapy with intensity-modulated radiotherapy for head and neck cancer.
    Batth SS; Caudell JJ; Chen AM
    Head Neck; 2014 Feb; 36(2):291-8. PubMed ID: 23508721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
    Stewart AJ; Lee YK; Saran FH
    Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of IMRT planning with two-step and one-step optimization: a strategy for improving therapeutic gain and reducing the integral dose.
    Abate A; Pressello MC; Benassi M; Strigari L
    Phys Med Biol; 2009 Dec; 54(23):7183-98. PubMed ID: 19920309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.
    Guerrero Urbano MT; Clark CH; Kong C; Miles E; Dearnaley DP; Harrington KJ; Nutting CM; PARSPORT Trial Management Group
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):604-13. PubMed ID: 17706404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.